Clean Genome® Platform for pDNA
Manufacturing Enabler for Gene/Cell Therapy & mRNA Vaccines
Partnership/DevelopmentActive
Key Facts
Indication
Manufacturing Enabler for Gene/Cell Therapy & mRNA Vaccines
Phase
Partnership/Development
Status
Active
Company
About Scarab Genomics
Scarab Genomics leverages synthetic biology to create optimized bacterial production platforms and essential biopharmaceutical components. Its flagship technology is the Clean Genome® E. coli, a reduced-genome strain offering enhanced genetic stability and metabolic efficiency for producing proteins and plasmid DNA. The company generates revenue through product sales of strains, vectors, and carrier proteins (CRM197, Protein D), as well as through licensing agreements and partnerships, positioning it as a key enabler for vaccine developers and biomanufacturers.
View full company profile